A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Parabilis Medicines, Inc.
Bayer
AstraZeneca
Agenus Inc.
Mayo Clinic
Mayo Clinic
Karyopharm Therapeutics Inc
Kaiser Permanente
Children's Oncology Group
Institute of Cancer Research, United Kingdom
SEED Therapeutics, Inc.
MacroGenics
UNC Lineberger Comprehensive Cancer Center
Solve Therapeutics
University of Nebraska
Adela, Inc
National Institutes of Health Clinical Center (CC)
Tanabe Pharma America, Inc.
Blueprint Medicines Corporation
UNC Lineberger Comprehensive Cancer Center
Leap Therapeutics, Inc.
Leap Therapeutics, Inc.
National Cancer Institute (NCI)
Numab Therapeutics AG
PharmaMar
NextPoint Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Tempus AI
Esperas Pharma Inc.
Region Skane
University of South Florida
Northwestern University
Memorial Sloan Kettering Cancer Center
Deciphera Pharmaceuticals, LLC
Mundipharma Research Limited
Brown University
Xencor, Inc.
Prelude Therapeutics
University Hospital, Gasthuisberg
Innolake Biopharm
Celon Pharma SA
Corvus Pharmaceuticals, Inc.
pharmaand GmbH
Canadian Cancer Trials Group
Genmab